Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008911 · ClinicalTrials.gov registry record · NA
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
A NA study of Aortic Valve Stenosis and Aortic Valve Disease, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07008911: Recruiting NA study of Aortic Valve Stenosis and Aortic Valve Disease, sponsored by University of Colorado, Denver.
NCT07008911 is a NA study of Aortic Valve Stenosis and Aortic Valve Disease that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 200 participants, below the 1,037-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07008911, a NA study of Aortic Valve Stenosis and Aortic Valve Disease, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
Primary Outcome
Change in mean daily steps from baseline to 8 weeks, measured using smartwatch accelerometer data collected through the Ortus platform. Steps will serve as the primary endpoint to evaluate the effect of CardioHeartConnect compared with control.
Conditions Studied
Interventions
- BEHAVIORAL CardioHeartConnect
- BEHAVIORAL CardioHeartEd
Study Locations (1)
Colorado
- UCHealth Structural Heart and Valve Clinic - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
What NCT07008911 shows while recruiting
NCT07008911 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,037-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 2 interventions - of which CardioHeartConnect is the first listed.
NCT07008911 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07008911 about?
NCT07008911 is a clinical study titled "CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation". This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activ...
What is the current status of trial NCT07008911?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-09-30. Estimated completion is 2029-08-01.
What conditions does trial NCT07008911 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis, Aortic Valve Disease.
What interventions are being tested in trial NCT07008911?
The interventions under investigation include: CardioHeartConnect (BEHAVIORAL), CardioHeartEd (BEHAVIORAL).
Who is sponsoring clinical trial NCT07008911?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07008911 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07008911's enrollment target sits among peer trials
200 14th of 30 higher than 15 of 30 other Aortic Valve Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI